Introduction {#sec1}
============

In the case of infectious diseases, it is crucial to clearly establish the diagnosis of infections to identify the pathogens as rapidly as possible. Diagnosis is necessary to prescribe the most adequate treatment; it is also a tool for epidemiology survey and prevention. They are four main techniques to identify an infection and eventually the pathogen. The oldest technique is the identification by microcopy. The second is based on phenotypic identification using methods such as the analytical profile index. The third is based on the detection of some microbial antigens or the patient\'s immune response. The last one is based on the detection of the genetic material from the causative agent using PCR techniques. Sequencing of amplicons can be performed for a more accurate identification. Unfortunately, these techniques are time and money consuming. They also require skilled staff as well as specific equipment and consumables. Indeed, they cannot be performed outside specialized laboratories. Recently a new method of microbe identification has appeared: matrix-assisted desorption ionization--time of flight mass spectrometry (MALDI-TOF MS). This is a simple and revolutionary technique that being more widely and routinely used in clinical microbiology [@bib1], [@bib2]. In addition, the IHU-FMI institute has developed a point-of-care (POC) laboratory for diagnosis, integrating systems based on immunology and/or genetic methods. MALDI-TOF MS and POC are complementary and simple; further, they enable nonspecialized staff to perform diagnostic assays at low cost. Consequently, they may be used as first-line tools in clinical microbiology laboratories in tropical countries.

Here we detail MALDI-TOF MS and POC methods and associated developments performed by the IHU-FMI institute in France but also in tropical Africa (Dakar, Senegal).

MALDI-TOF MS analysis {#sec2}
=====================

MALDI-TOF MS produces a mass spectrum that represents the masses of each ionized peptide in a sample (more specifically, the mass/charge ratio). When applied to bacteria, mass spectra may be obtained from either colonies in pure culture on agar or in complex samples such as blood. Consequently, MALDI-TOF MS is particularly suitable for the identification of pathogenic microorganisms in the medical field. It allows the identification of a strain by matching its mass spectrum with a database of Main SPectra from numerous well-characterized bacteria. The IHU-FMI institute possesses eight MALDI-TOF mass spectrometers (MicroFlex LT/SH; Bruker Daltonics, Bremen, Germany).

The procedure is simpler and faster than conventional phenotypic and molecular methods ([Fig. 1](#fig1){ref-type="fig"}). The cost for analysing a single sample is quite low. Indeed, analysing a 96-sample MALDI plate requires €0.53 of reagents and consumables (alpha-Cyano-4-hydroxycinnamic acid (HCCA), Bacterial Test Standard (BTS), Trifluoroacetic acid (TFA), acetonitrile, ethanol). The plate can be prepared in 10 minutes by a laboratory technician. It is worth noting that a technician can be trained to use MALDI-TOF MS identification (biotyping) in just 2 days. The instrument will take an hour to analyse the plate. The major part of the cost comes from the purchase of the MALDI-TOF MS instrument (€160 k for a complete system) and its maintenance (€25 k per year). One MALDI-TOF mass spectrometer can perform roughly 142\<thinsp\>000 spot analyses per year at IHU-FMI. From these data, we estimate the consolidated cost of a strain identification at the IHU-FMI at €0.45, including €0.05 for the cost of consumables and labor.Fig. 1Preparation and identification of a sample by MALDI-TOF MS. MALDI-TOF MS, matrix-assisted desorption ionization--time of flight mass spectrometry.Fig. 1

Because the identification by MALDI-TOF MS is simple, fast, reliable and cheap, the IHU-FMI institute has developed protocols and implemented databases for numerous applications ([Table 1](#tbl1){ref-type="table"}). In microbiology, MALDI-TOF MS is routinely used to identify bacteria and yeasts [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7]. Proofs of concepts have been validated for the *Archaea* [@bib8] as well as giant viruses [@bib9]. In addition, some bacterial resistances to antibiotics can be surveyed by following the disappearance of the antibiotic peaks degraded by the bacteria [@bib10]. Furthermore, because arthropods are vectors of several tropical diseases, we investigated whether MALDI-TOF MS could be used in entomology [@bib11]. We demonstrated that it is possible to identify at the species level various arthropods [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23], [@bib24] based on the legs at the adult stage for ticks and mosquitoes, or other body parts for fleas and *Culicoides,* but also at the larval stage [@bib25], [@bib26]. This approach has been further developed for the dual identification of arthropods and vector-borne pathogens such as *Plasmodium* [@bib27], filariae [@bib28], *Borrelia* [@bib29] and *Rickettsia* [@bib30], as well as for the identification of mosquitoes\' blood meal origin [@bib31], [@bib32]. This illustrates that MALDI-TOF MS is well suited for vector-borne disease survey. Some developments have been made for cell or tissue identification [@bib33], [@bib34], [@bib35], [@bib36], [@bib37], including tumours [@bib38]. Applications in the field of traceability are also available for fast detection of microorganism contamination in platelet concentrates [@bib39], [@bib40] and animal food origin [@bib41].Table 1MALDI-TOF MS methods developed by IHU-Méditerranée Infection in collaboration with Marseille and Dakar research teamsTable 1MALDI-TOF-MS identificationReferenceBacteria*Mycobacterium*[@bib3]*Yersinia*[@bib4]*Legionella*[@bib6]*Bartonella*[@bib5]Antibiotic resistance[@bib10]*Archaea*[@bib8]Yeast[@bib7]Giant viruses[@bib9]ArthropodsMosquitoes[@bib12], [@bib13], [@bib14], [@bib15]Blood meal origin of mosquitoes[@bib31], [@bib32]Mosquito larvae[@bib25], [@bib26]Vectorized pathogens in mosquitoes[@bib27], [@bib28]Fleas[@bib16], [@bib17]Triatomines[@bib18]Ticks and associated bacteria[@bib16], [@bib19], [@bib20], [@bib21], [@bib22], [@bib29], [@bib30]Phlebotomines[@bib23]*Culicoides*[@bib24]Tissues or cells IDDental pulp[@bib33]Cancer[@bib38]Immune cell[@bib34], [@bib35], [@bib36], [@bib37]TraceabilityFood origin[@bib41]Bacterial contaminations of platelets[@bib39], [@bib40][^1]

The performance of the identification depends on the sample (protein extraction, molar ratio between sample and matrix), which should be the most reproducible possible, and the quality of the reference spectrum (databases should be exhaustive). Our laboratory notably made huge efforts to cultivate as many bacterial members from the human gut as possible using the culturomics strategy, which enabled the discovery of more than 197 new species [@bib42]. For each of these new species, a reference mass spectrum was added to the in-house bacterial database.

The laboratory also helped install a MALDI-TOF MS system (Vitek MS, bioMérieux, Marcy l'Etoile, France) in the Principal Hospital in Dakar in 2012. This was the first MALDI-TOF MS implemented in Africa. This device is currently routinely used in the clinical microbiology laboratory [@bib7], [@bib43], [@bib44]. It has allowed the discovery and description of new bacterial species [@bib45], [@bib46], [@bib47], [@bib48] as well as the creation of a database for the identification of *Culicoides* biting midges [@bib24]. This illustrates that MALDI-TOF MS is a robust, reliable and appropriate instrument for Africa. We plan to implement MALDI-TOF MS systems in Algeria and Mali.

Point of care {#sec3}
=============

POC laboratories are close-to-patient small laboratories providing rapid (\<2 hours) diagnosis of infectious diseases [@bib49]. We have implemented two such POCs in rural Senegal, in Dielmo and Niakhar villages [@bib50] ([Fig. 2](#fig2){ref-type="fig"}). Both POCs are operated around the clock by a technician who has been trained in the use of immunochromatographic tests such as the rapid diagnosis test for influenza A and B virus detection and in the use of real-time PCR tests for bacteraemia investigations. Samples are collected in febrile patients who seek care at health posts located in the villages of Dielmo, Ndiop (Dielmo POC) and Toucar, Diohine and Ngayokhem (Niakhar POC). Complete DNA extraction is done on site using the DNA kit for blood extraction. All PCR mixes are prepared monthly in Marseille, then lyophilized and shipped to Senegal. Lyophilization offers the advantage of easy shipment and storage. Before amplification, the mixes are prepared by adding RNAse-free water. Tests are combined in order to provide a syndromic-based diagnosis ([Fig. 3](#fig3){ref-type="fig"}) and to guide the medical management of patients. The fact that a total of 5226 tests have been performed within 8 years, including 3352 tests in Dielmo and 1874 in Niakhar (from November 2010 to December 2017), in the two Senegalese POCs testifies to the usefulness of this new approach for rapid and near-patient diagnosis. Moreover, POC data form the basis for the syndrome-based surveillance of infections in rural Senegal [@bib51].Fig. 2Study sites.Fig. 2Fig. 3Chronology of POC diagnosis. POC, point of care.Fig. 3

Conclusion {#sec4}
==========

The implementation and operation of POCs and MALDI-TOF MS in Senegal illustrate the contribution of latest technologies to healthcare in West Africa, as well as the necessity to bypass intermediate technologies and approaches to instead implement cutting-edge methods to promote health.
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[^1]: MALDI-TOF MS, matrix-assisted desorption ionization--time of flight mass spectrometry.
